We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.51%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$28.5B
AUM Growth
+$2.42B
(+9.3%)
Cap. Flow
+$581M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
1,921
New
171
Increased
1,320
Reduced
356
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
VF Corp
VFC
|
+$73.4M |
| 3 |
Amazon
AMZN
|
+$71M |
| 4 |
Stanley Black & Decker
SWK
|
+$60.2M |
| 5 |
Tesla
TSLA
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$158M |
| 2 |
Apple
AAPL
|
+$130M |
| 3 |
Cardinal Health
CAH
|
+$43.7M |
| 4 |
Fortinet
FTNT
|
+$39.6M |
| 5 |
ExxonMobil
XOM
|
+$32.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.73% |
| 2 | Industrials | 12.07% |
| 3 | Consumer Staples | 11.64% |
| 4 | Healthcare | 11.12% |
| 5 | Financials | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
1551
DELISTED
Everi Holdings
EVRI
| $159K | ﹤0.01% |
+11,103
| New | +$184K |
|
1552
Theravance Biopharma
TBPH
$874M
| $157K | ﹤0.01% |
13,974
+446
| +3% | +$4.69K |
|
1553
DHT Holdings
DHT
$2.97B
| $157K | ﹤0.01% |
17,626
+2,526
| +17% | +$23K |
|
1554
Adeia
ADEA
$2.86B
| $156K | ﹤0.01% |
16,474
-37,678
| -70% | -$383K |
|
1555
ADMA Biologics
ADMA
$1.92B
| $156K | ﹤0.01% |
40,188
+3,184
| +9% | +$9.82K |
|
|
FTCH
1556
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $155K | ﹤0.01% |
32,755
+4,307
| +15% | +$30K |
|
1557
Arcutis Biotherapeutics
ARQT
$3.42B
| $154K | ﹤0.01% |
+10,379
| New | +$181K |
|
1558
BGC Group
BGC
$5.58B
| $153K | ﹤0.01% |
40,575
+5,346
| +15% | +$21.1K |
|
|
GAP
1559
The Gap Inc
GAP
$6.84B
| $151K | ﹤0.01% |
13,405
+1,301
| +11% | +$15.6K |
|
|
ETWO
1560
DELISTED
E2open Parent Holdings
ETWO
| $150K | ﹤0.01% |
25,637
+3,674
| +17% | +$21K |
|
1561
Cytek Biosciences
CTKB
$576M
| $150K | ﹤0.01% |
14,693
+2,106
| +17% | +$28.3K |
|
|
ADAM
1562
Adamas Trust
ADAM
$777M
| $150K | ﹤0.01% |
14,609
+1,559
| +12% | +$16.6K |
|
1563
3D Systems Corp
DDD
$420M
| $149K | ﹤0.01% |
20,128
+2,611
| +15% | +$22.9K |
|
1564
Alignment Healthcare
ALHC
$4.02B
| $149K | ﹤0.01% |
+12,656
| New | +$154K |
|
1565
Lyell Immunopharma
LYEL
$309M
| $149K | ﹤0.01% |
2,144
+148
| +7% | +$14.7K |
|
1566
Cinemark Holdings
CNK
$3.82B
| $149K | ﹤0.01% |
17,150
+2,215
| +15% | +$25K |
|
1567
Liberty Latin America Class C
LILAK
$1.5B
| $148K | ﹤0.01% |
21,459
+2,491
| +13% | +$17K |
|
1568
Remitly
RELY
$4.74B
| $148K | ﹤0.01% |
12,893
+2,017
| +19% | +$20.9K |
|
1569
Perdoceo Education
PRDO
$1.9B
| $148K | ﹤0.01% |
+10,612
| New | +$135K |
|
|
LADR
1570
Ladder Capital
LADR
$1.25B
| $147K | ﹤0.01% |
14,620
+2,096
| +17% | +$21.7K |
|
1571
FuelCell Energy
FCEL
$1.7B
| $146K | ﹤0.01% |
1,753
+322
| +23% | +$31K |
|
1572
ProPetro Holding
PUMP
$1.45B
| $146K | ﹤0.01% |
14,045
+2,030
| +17% | +$21.4K |
|
|
VVNT
1573
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $145K | ﹤0.01% |
12,215
+1,751
| +17% | +$15.8K |
|
|
PDM
1574
Piedmont Realty Trust
PDM
$1.22B
| $145K | ﹤0.01% |
15,820
+2,266
| +17% | +$22.4K |
|
1575
Warby Parker
WRBY
$3.01B
| $145K | ﹤0.01% |
+10,741
| New | +$164K |
|
Similar funds
ProShare Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, ProShare Advisors held 1,921 positions worth $28.5B, up 9.3% from $26.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ProShare Advisors's Q4 2022 filing shows 171 new, 1,320 increased, 356 reduced and 71 closed positions. Its largest new stake was Rivian: 689,839 shares worth $12.7M. The largest sale was Target, an estimated $158M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q4 2022 buy was Rivian: 689,839 shares worth $12.7M.
- ProShare Advisors added most to Microsoft in Q4 2022, an estimated $111M increase.
- ProShare Advisors's biggest Q4 2022 reduction was Apple, cutting an estimated $130M.
- ProShare Advisors fully exited Target in Q4 2022, selling an estimated $158M.
- ProShare Advisors's ten largest holdings make up 20% of its $28.5B portfolio in Q4 2022.
- ProShare Advisors opened 171 new positions and closed 71 in Q4 2022.
- ProShare Advisors's portfolio value rose 9.3% quarter-over-quarter to $28.5B.
Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.